Skip to main content

Table 5 Ovary

From: Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis

Author Cases n Controlsa/Cohortb Source population Exposure definition Exposure assessment Drug RR 95% CI
Tzonou et al. [47] 189 200a Hospital based >2 tablets/week Personal Interview NSAIDs (26%) 0.51 0.26–1.02
Cramer et al. [28] 563 523a Population based >1 tablet/week for >6 months. 1 year lag time. Personal Interview Aspirin(14%) 0.75 0.52–1.10
       NSAIDs (7%) 0.91 0.53–1.54
Tavani et al. [45] 749 898a Hospital based >1 tablet/week for >6 months. (current and/or former) Personal Interview Aspirin (6%) 0.93 0.53–1.62
Rosenberg[56] 448 4,906a Hospital based >3 days/week for >3 months 1.5 years of lag time Personal Interview NSAIDs (6%) 0.8 0.5–1.3
Rosenberg et al. [42] 780 2,570a Hospital based >4 days/week for at least 6 months.1 year lag time Personal Interview Aspirin (5%) 0.8 0.5–1.2
       NA-NSAIDs (3%) 0.5 0.3–1.0
       NSAIDs (8%) 0.7 0.5–1.0
Moysich et al. [37] 547 1,094a Hospital based >1 day/week for 6 consecutive months In-hospital Questionnaire Aspirin (12%) 1.00 0.73–1.39
Akhmedkhanov et al. [21] 68 680a Population based Ever use of >3 tablet/week for >6 months. 1 year lag time Mailed Questionnaire Aspirin (16%) 0.60 0.26–1.38
Meier et al. [61] 483 1,877a Population based ≥30 prescriptions. 1 year lag time Automated Database NSAIDs (5%) 1.1 0.6–1.8
Fairfield et al. [50] 333 76,821b Cohort >1 tablet/week Mailed Aspirin (46%) 1.00 0.80–1.25
       NSAIDs (N.R.) 0.60 0.38–0.95
  1. Prevalence of exposure among controls/cohort; Over-the-counter only; Prescription only.